BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jul 30, 2022
Data Byte

Assessing an expanse of ALS targets 

Restoring neurotransmission may be the key to slowing fatal disease
BioCentury | Feb 6, 2019
Distillery Therapeutics

Neurology

BioCentury | Jan 5, 2018
Finance

Scholar goes to the clinic

Why Scholar Rock will use $47M series C to advance platform alongside SRK-015
BioCentury | Aug 24, 2015
Company News

Ember Therapeutics, Knight Therapeutics deal

BioCentury | Mar 23, 2015
Company News

Ember Therapeutics, Mariel deal

BioCentury | Oct 29, 2012
Clinical News

NeoStem preclinical data

BioCentury | Oct 11, 2012
Cover Story

Ember: warming up to brown fat

BioCentury | Jul 26, 2012
Distillery Techniques

Technology: Disease models

BioCentury | May 31, 2012
Targets & Mechanisms

Going to BAT

BioCentury | Apr 2, 2012
Company News

Ember Therapeutics, Joslin Diabetes Center deal

Items per page:
1 - 10 of 16